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Abstract
Objective To determine whether Olympic medallists live longer than the
general population.
Design Retrospective cohort study, with passive follow-up and
conditional survival analysis to account for unidentified loss to follow-up.
Setting and participants 15 174 Olympic athletes from nine country
groups (United States, Germany, Nordic countries, Russia, United
Kingdom, France, Italy, Canada, and Australia and New Zealand) who
won medals in the Olympic Games held in 1896-2010. Medallists were
compared with matched cohorts in the general population (by country,
age, sex, and year of birth).
Main outcome measures Relative conditional survival.
ResultsMore medallists than matched controls in the general population
were alive 30 years after winning (relative conditional survival 1.08, 95%
confidence interval 1.07 to 1.10). Medallists lived an average of 2.8 years
longer than controls. Medallists in eight of the nine country groups had
a significant survival advantage compared with controls. Gold, silver,
and bronze medallists each enjoyed similar sized survival advantages.
Medallists in endurance sports and mixed sports had a larger survival
advantage over controls at 30 years (1.13, 1.09 to 1.17; 1.11, 1.09 to
1.13) than that of medallists in power sports (1.05, 1.01 to 1.08).
ConclusionsOlympic medallists live longer than the general population,
irrespective of country, medal, or sport. This study was not designed to
explain this effect, but possible explanations include genetic factors,
physical activity, healthy lifestyle, and the wealth and status that come
with international sporting glory.
Introduction
Pierre de Coubertin, founder of the modern Olympics,
introduced the Olympic motto “citius, altius, fortius” (swifter,
higher, stronger) to describe the sporting aspirations of athletes.1
It is also an apt description of Olympians, who represent the
pinnacle of human fitness and physical achievement. Do
Olympians enjoy longer life?
There are no large scale published studies of the longevity of
Olympians, and the evidence onwhether elite athletes live longer
is mixed.2 German international soccer players were recently
shown to have a shorter life expectancy thanmatchedmen from
the general population.3 Studies of Danish athletic champions,4
New Zealand international rugby players,5 and USmajor league
baseball players6 have found no differences, and an early review
of the literature reached the same conclusion.7 By contrast,
analyses of Polish Olympians,8 the Italian national track and
field team,9major league baseball players,10 and selected tennis
champions and Olympic medallists in several sports and years11
have identified survival advantages compared with the general
population. Studies of Finnish athletes in various sports found
lower standardised mortality ratios among competitors in
endurance, team, and “mixed” sports, but not among competitors
in “power” sports.12 13 Most research has focused on athletes
from one country in a particular sport.
Since the modern Olympic era began in 1896, nearly 25 000
athletes competing under 136 different flags have won medals.
Most medallists come from a small number of countries,
including the United States, Germany, Russia, and United
Kingdom. We compared the longevity of these medallists to a
matched cohort of their compatriots from the general population.
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The OlyMADMen, an international consortium of Olympic
historians and statisticians, has collected data since the 1980s
on all Olympians. Much early data came from primary research
conducted for books14 15 coauthored by one author of the present
study (WJM), a member of OlyMADMen and former president
and cofounder of the International Society of Olympic
Historians. OlyMADMen is widely regarded as the most
authoritative source of information on Olympians. The
International Olympic Committee (IOC) has used information
from theOlyMADMen database to complete its official archives.
The OlyMADMen database draws on various sources. Names
and demographic information are obtained from official
competitor lists. Biographical information is complemented
with data from national Olympic historians, as well as official
sources such as birth registers. Information on events and
placings comes from official reports and results from each
Olympics, supplemented with magazines and newspapers for
the early years. Information on Olympians’ deaths is obtained
from friends and relatives, internet searches, international
professional sporting clubs and bodies, and published obituaries.
Since 2008, a form of the database was made available online,16
allowing Olympians, their friends and relatives, and other
visitors to advise on corrections and additions.
Study variables and sample
The OlyMADMen database contains information on 118 442
athletes who participated in the 27 summer and 21 winter games
held from the first modern Olympics in Athens in 1896 to
Vancouver in 2010. (At the time of data extraction for our study,
the OlyMADMen database did not include information on
medallists from the 2012 Games in London.) Variables in the
database included Olympians’ sex, birth date, and death date;
the year, sports, and events competed; event placings; and
countries represented.
One or more medals were won by 24 785 athletes competing
for 136 different countries and geopolitical entities. However,
nine countries or country groups (each with >850 medallists)
accounted for most Olympic medallists in the modern era (n=15
820; 63.8%). These groups are: the US, Nordic countries
(Denmark, Finland, Iceland, Norway, and Sweden), Russia (the
Russian Empire, Soviet Union, and Russia), Germany (the
German Empire, Interbellum Germany, East Germany, West
Germany, and reunified Germany), UK, France, Italy, Canada,
and Australia and New Zealand. We focused the analysis on
medallists from these countries.
For Germany and Russia, we restricted the sample to medallists
fromOlympics after 1950. This was because life table coverage
for German medallists was poor during the first and second
world wars, which undermined construction of comparator
cohorts in the general population. Russia had only a small
number of medallists before 1950.
Medallists who represented more than one country group or
competed in more than one sport or games, were classified on
their status when they won their first medal. After excluding
214 medallists with missing birthdates, the final study sample
consisted of 15 174 medallists. Although other variables of
interest had trivial numbers of missing values, death dates posed
an analytical challenge.
Ascertainment of death dates
An absent date of death generally indicated that a medallist was
alive, but some deaths could have been missed. OlyMADMen
monitors Olympian deaths, although some loss to follow-up is
inevitable with irregular contact with cohort members.17 We
could not identify who was lost to follow-up, yet this had to be
accounted for in the survival analysis to avoid overestimating
survival.
Accounting for unidentified loss to follow-up
among medallists
We used a technique described by Tallis and colleagues,17which
conditions survival on death before a specified number of years
of follow-up (in our analyses, we chose 60 years). This
conditional approach to survival analysis is unaffected by
unidentified loss to follow-up, provided the losses are
independent of follow-up time and model covariates. If either
of these conditions is not met, the approach is still reliable as
long as unidentified loss to follow-up does not exceed 10-15%
of the cohort.17
Although loss to follow-up in our cohort was unknown, it was
unlikely to exceed 10-15%. An estimate can be derived by
analysing death dates recorded for medallists up to and including
the summer games and winter games of 1928. OlyMADMen
run a project tracking the oldest Olympians, and there is believed
to be only one living competitor from this period. Records for
the first four modern games (1896, 1900, 1904, 1906) were less
complete than later years, and 121 (18%) medallists did not
have recorded death dates. For the next seven games (summer
1908, 1912, 1920, 1924, 1928; winter 1924, 1928), 128 (5%)
medallists had no date of death. Overall, these early games
averaged 8% loss to follow-up.
Life tables
To assess medallists’ longevity, we used comparators from life
tables for the general population.We obtained period life tables
for the nine country groups from publicly available sources.
The life tables had excellent coverage of the modern Olympic
era (web appendix).
Each medallist was matched by birth year, sex, and age to the
life table of the country they represented. We then constructed
a survival curve for each “average comparator” in the general
population by tracking their hazard from year to year across the
period life tables (that is, converting period life tables to cohort
life tables). Next, we constructed an overall comparator survival
curve by combining18 individual curves derived from general
populations.
Statistical analysis
Our analyses compared survival among medallists with that
among corresponding cohorts from the general population.
Relative survival was defined as actual survival among
medallists divided by their expected survival (based on survival
of the general population cohorts). Because we used Tallis and
colleagues’ method to adjust for unidentified loss to follow-up,17
we reported relative survival that was conditional on death
occurring within 60 years of the first medal won. We used an
approach based on Fieller’s theorem to obtain confidence
intervals.19
To quantify the additional life expectancy of medallists, we
computed conditional survival curves for the medallist and
general population cohorts, and took the difference of the area
under each curve. To avoid immortal time bias,20 survival
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e8308 doi: 10.1136/bmj.e8308 (Published 13 December 2012) Page 2 of 8
FEATURE
estimates for each medallist began from the winning of their
first medal, which was not necessarily their first Olympics.
After calculating the overall relative conditional survival for
medallists, we examined relative survival by country group,
medal, and sport. The sports analysis focused on a subsample
of 4583 (30%)medallists grouped into categories used byKujala
and colleagues in a 2001 analysis of Finnish athlete longevity,13
specifically: endurance (long distance running, cross country
skiing), mixed (soccer, ice hockey, basketball, track and field
jumping, short distance running), and power (weightlifting,
wrestling, boxing, track and field throwing).
Results
Medallists were mostly men and had a mean age of 26 years
(table⇓). The nine country groups that produced the most
medallists accounted for 64% of all medallists. By 15 March
2012, 5095 (34%) medallists had died.
Figure 1⇓ reports the survival of medallists from the nine
country groups relative to the general population. At 10 years,
2% more of the medallist cohort were alive; at 30 years, 8%
more of the medallist cohort were alive (relative conditional
survival 1.02, 95% confidence interval 1.01 to 1.02; 1.08, 1.07
to 1.09). On average, medallists lived 2.8 years longer.
This survival advantage occurred in eight country groups,
although the size of the advantage varied (fig 2⇓). At 30 years,
medallists from Russia (relative conditional survival 1.18, 95%
confidence interval 1.16 to 1.20), France (1.10, 1.05 to 1.15),
Italy (1.07, 1.03 to 1.11), Australia and New Zealand (1.06,
1.01 to 1.11), Germany (1.05, 1.03 to 1.06), Nordic countries
(1.05, 1.03 to 1.08), and the UK (1.04, 1.00 to 1.08) had a
survival advantage over their matched compatriots. The survival
advantage of Canadian medallists at 30 years over the general
population was not significant (1.04, 0.99 to 1.08).
Grouping Olympians by the type of medal won showed similar
survival advantages for gold, silver, and bronze medallists (fig
3⇓). At 30 years, Olympic medallists in endurance sports
(relative conditional survival 1.13, 95% confidence interval
1.09 to 1.17) and mixed sports (1.11, 1.09 to 1.13) had a larger
survival advantage over the general population than did those
in power sports (1.05, 1.01 to 1.08; fig 3).
Discussion
In this study of Olympic medallists from nine country groups
that have won the most medals, medallists averaged longer
lifespans, compared with matched cohorts in the general
population. This advantage was significant in eight of the nine
country groups examined, and across different types of medals
and sports.
Comparison with other studies
Our findings broadly accord with other studies identifying
survival advantages among elite athletes. 8-13 Although some
studies have found longevity not to differ between athletes and
the general population,4-6most of these studies are older and
tracked athletes who competed in the first half of the twentieth
century, which may explain the discrepancy in findings.
A review by Teramoto and Bugnum2 raises another possible
explanation for conflicting results in studies of elite athletes’
longevity. Athletes in some types of sport (such as endurance)
have longer than average lifespans, while those in other sport
types do not. Our sport subanalyses mimicked categories used
in a 2001 study,13 which found that elite Finnish athletes in
endurance and mixed sports lived longer than the general
population, but athletes in power sports did not. We found
medallists in all three categories to have a survival advantage.
Our study had a larger sample, included athletes from many
countries, used a different analytical method, and focused on
Olympic medallists only
Interpretation of findings
Why do Olympic medallists live longer? Our study aimed to
test whether medallists’ had a survival advantage, not to identify
reasons for this, so the following explanations are speculative.
One explanation is that athletes are much healthier than the
average person. Part of this advantage could be genetic, but
environmental factors undoubtedly amplify genetic advantages.
Young athletes who exhibit exceptional physical talents are
often selected into national training squads to undergo intensive
physical training over many years. Most Olympic medallists
will have come through such programmes.
Strong evidence indicates that physical activity confers many
health benefits, including improved functional health status and
reduced risks of cardiovascular disease, coronary heart disease,
stroke, depression, type 2 diabetes, and breast and colon
cancer.21 22 Studies of the relation between all cause mortality
and physical activity generally show large reductions in
mortality risk with low to moderate levels of activity, and small
additional reductions at high activity levels.21 The physical
activity and fitness of elite athletes are usually at the extreme
end of the spectrum. Thus, they should at least enjoy the survival
advantages linked to vigorous exercise.
Nonetheless, for most elite athletes, the period spent training
intensively and competing occupies a minority of their life.
Surveys of retired Finnish athletes, including Olympians, have
shown lower than average rates of smoking,23-25 ischaemic heart
disease and diabetes,26 and depression and anxiety,25 but possibly
higher rates of musculoskeletal conditions such as
osteoarthritis.23 26 These former athletes also seemed to remain
physically active.
Another explanation relates to the wealth and fame that
international sporting success confers on many medallists.
Evidence strongly indicates that higher socioeconomic status
is associated with lower mortality.27 Improved nutrition,
education, and access to medical services all mediate this
effect.28 The influence of social status on mortality risk,
independent of wealth, is more controversial, although many
studies have identified such an effect.29Unlike other studies that
have examined relative survival among celebrities of varying
degrees of fame,30 we observed no clear longevity differences
bymedallists’ stature; similar survival advantages were observed
among gold, silver, and bronze medallists.
Study strengths and weaknesses
A major strength of our study was its scale; we used
comprehensive data for many elite athletes from various
populous countries over 115 years. However, we could not
identify exactly howmany andwhich deaths weremissed among
medallists after 1930. Instead, we used a form of relative
survival that is robust to systematic unidentified loss to
follow-up, provided that the proportion lost is moderate.
However, if the loss in our sample substantially exceeded that
observed in early years and varied systematically over time, this
method could have underestimated or overestimated relative
conditional survival.
By examining relative survival by country, medal, and
sport—our study provided limited evidence that the advantage
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was somewhat durable, but it was not designed to explain why
medallists live longer. We did not have information on causes
of death, medallists’ health related behaviours, or lifestyle
factors (including drug and alcohol use) relative to the general
population. Therefore, we could not adjust our results for these
variables.
Finally, our analysis compared Olympic medallists with the
general population. Athletes generally, not merely the elite,
could have similar survival advantages. Isolating a pure
“Olympic effect” would need a different study design—for
instance, comparing the longevity of high performing athletes
who do not make it to the Olympics with those who do.
Conclusion
The elite warrior Achilles in Greek mythology was forced to
choose between a short glorious life and a long obscure one.31
There is no such trade off for Olympic medallists.
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What is already known on this topic
Evidence on whether elite athletes live longer is mixed and whether Olympic medallists do so is not known
What this study adds
Olympic medallists live longer than the general population, irrespective of country, medal, or sport
Possible explanations include genetic factors, physical activity, healthy lifestyle, and the wealth and status that come with international
sporting glory
Table
Table 1| Characteristics of Olympic medallists, 1896-2010*
No (%) of medallists (n=15 174)
Demographics
11 619 (77)Male































3222 (21)1896-1928 (9 summers, 2 winters)
2781 (18)1932-60 (6 summers, 6 winters)
4876 (32)1964-88 (7 summers, 7 winters)
4295 (28)1992-2010 (5 summers, 6 winters)
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For medallists involved with multiple Olympics, sports, and medals, all characteristics pertain to the first medal won.
†Excludes medallists after 1950, and 214 medallists with missing birth dates.
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e8308 doi: 10.1136/bmj.e8308 (Published 13 December 2012) Page 6 of 8
FEATURE
Figures
Fig 1 Survival of Olympic medallists from selected countries relative to the general population, 1896-2012
Fig 2 Survival of Olympic medallists, by country group. *Excludes medallists from Olympic Games before 1950
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Fig 3 Survival of Olympic medallists by medal and sport. *Analysis based on subsample (30%) of all medallists from the
nine country groups
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